The dominant hypothesis that has been held for over 100 years about the etiology of Alzheimer’s disease, and most of the wide-ranging therapeutic struggles in both scientific research and clinical trials, have been built around amyloid and tau protein as the causative agents of the disease [4,5]. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.